Thomas Eric Schmidt Net Worth & Insider Trades

Thomas Eric Schmidt - Chief Financial Officer, Allogene Therapeutics, Inc

As of March 17, 2022

What is Thomas Eric Schmidt's Net Worth?

The current estimated net worth of Allogene Therapeutics, Inc's Chief Financial Officer, Thomas Eric Schmidt, is estimated to be about $15.72M . Thomas Eric Schmidt owns about 1,253,141 units of Allogene Therapeutics, Inc common stock. In the last 3 years at Allogene Therapeutics, Inc, Thomas Eric Schmidt has sold an estimated value of $9.08M worth.

What is Thomas Eric Schmidt's Past Insider Trading?

Thomas Eric Schmidt's largest sale order was 30,000 units , worth over $945.47K on January 19, 2021. In total, Thomas Eric Schmidt has made about 12 transactions over 3 years of their time at Allogene Therapeutics, Inc. Thomas Eric Schmidt usually trades in March, with the busiest year in 2020. The most recent transaction was a sale order of 11,469 units , worth over $87.55K on March 17, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Thomas Eric Schmidt's Salary in 2020?

As Chief Financial Officer of Allogene Therapeutics, Inc, Thomas Eric Schmidt has a total base salary of $440,000 . Thomas Eric Schmidt received compensation valued at about $2,483,819 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of stock awards of $561,176 , option awards of $1,262,643 , other earnings, plans or compensations of $220,000 , and

What is Thomas Eric Schmidt's' Mailing Address?

  • Mailing address is C/o Allogene Therapeutics, Inc. 210 East Grand Avenue South San Francisco CA 94080 CA

Allogene Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David Chang, M.D., Ph.D. 2020 $675,000 - - $6,550,535 $506,250 $83,256 $7,815,041
David Chang, M.D., Ph.D. 2019 $600,000 - $4,651,970 $5,327,140 $363,000 $250,000 $11,192,110
David Chang, M.D., Ph.D. 2018 $362,413 - $8,948,152 $3,070,331 $217,641 $250,000 $12,848,537
Eric Schmidt, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Eric Schmidt, Ph.D. 2019 $425,000 - $1,328,366 $1,519,700 $187,000 - $3,460,066
Eric Schmidt, Ph.D. 2018 $201,232 - - $2,299,658 $88,099 - $2,588,989
Rafael Amado, M.D. 2020 $510,000 $75,000 $561,176 $1,262,643 $255,000 - $2,663,819
Rafael Amado, M.D. 2019 $145,833 - $4,249,976 $2,759,623 $71,726 $225,000 $7,452,158
Alison Moore, Ph.D. 2020 $440,000 - $561,176 $1,262,643 $220,000 - $2,483,819
Alison Moore, Ph.D. 2019 $425,000 - $996,275 $1,519,700 $187,000 - $3,127,975
Alison Moore, Ph.D. 2018 $233,265 - - $1,401,225 $102,124 $100,000 $1,836,614
Veer Bhavnagri 2020 $425,000 - $537,490 $1,211,953 $212,500 $9,385 $2,396,328
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm

What are Allogene Therapeutics, Inc's Past Insider Trades?

Allogene Therapeutics, Inc's most recent insider trade came on August 15, 2022 by Owen Witte who sold 15,000 units worth $251.25K . In the last 4 years, insiders at Allogene Therapeutics, Inc have sold an estimated value of $152.51M and bought an estimated value of $33.14M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are David D Chang, President and CEO,  Rafael Amado, EVP R&D,  and Veer Bhavnagri, General Counsel .

Allogene Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1